This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Key Sessions
Dennis Burton, PhD
Isolation of Potent SARS-CoV-2 Neutralizing Antibodies and Protection from Disease in a Small Animal Model
The Scripps Research Institute
Hedda Wardemann, PhD
The Human B Cell Response to a Repetitive Malaria Parasite Protein
German Cancer Research Center (DKFZ)
Janice Reichert, Ph.D.
Antibodies to Watch in a Pandemic
mAbs / The Antibody Society / Reichert Biotechnology Consulting LLC
Serge Muyldermans, PhD
Nanobodies: In Which Applications Will They Make a Difference?
Vrije Universiteit Brussel
Jeanette Leusen, PhD
Engineered IgA as Cancer Therapeutic
University Medical Center Utrecht
Jannie Borst, PhD
TNF Receptor Targeting in Cancer Immunotherapy
Leiden University Medical School
Sergio Quezada, PhD
Immunotherapeutic Approaches to Cancer
UCL Cancer Institute